REG - Citadel Group Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical CoAnnouncement

05/12/2018 15:05

RNS Number : 5317J
Citadel Group
05 December 2018
 






















































































 
 
FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION

































































































(a) Full name of discloser:


Citadel Group




(b) Owner or controller of interests and short positions        
     disclosed, if different from 1(a):
     The naming of nominee or vehicle companies is
     insufficient.  For a trust, the trustee(s), settlor and
     beneficiaries must be named.








(c) Name of offeror/offeree in relation to whose relevant
     securities this form relates:
     Use a separate form for each offeror/offeree


TAKEDA PHARMACEUTICAL COMPANY LIMITED




(d) If an exempt fund manager connected with an
     offeror/offeree, state this and specify identity of
     offeror/offeree:








(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest
practicable date prior to the disclosure


04 December, 2018




(f)  In addition to the company in 1(c) above, is the
     discloser making disclosures in respect of any other
     party to the offer?
If it is a cash offer or possible cash offer, state "N/A"


SHIRE PLC

































































































2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

























































































Class of relevant security:


Common Stock  ISIN  JP3463000004








Interests


Short Positions








Number


%


Number


%




(1) Relevant securities owned and/or controlled:


0


0.00


2,730,187


0.34




(2) Cash-settled derivatives:


325,800


0.04


2,366,000


0.30




(3) Stock-settled derivatives (including options) and agreements to purchase/sell:


0


0.00


0


0.00




    TOTAL:


325,800


0.04


5,096,187


0.64


























































































































All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)





























































































Class of relevant security in relation to which subscription right exists:








Details, including nature of the rights concerned and relevant percentages:

































































































3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales





































































































Class of relevant security
ISIN  JP3463000004


Purchase/sale


Number of securities


Price per unit




Common Stock (ADR)


Sale


-88,182


17.975206  USD











































































































(b)        Cash-settled derivative transactions































































































Class of relevant security
 
ISIN  JP3463000004


Product description
e.g. CFD


Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


Number of reference securities


Price per unit




Common Stock


CFD


Increasing long position


92,800


4184.64439655  JPY




Common Stock


CFD


Increasing long position


7,900


4186.62222222  JPY




Common Stock


CFD


Increasing long position


13,800


4191.594203  JPY




Common Stock


CFD


Increasing long position


900


4193.61111111  JPY




Common Stock


CFD


Increasing long position


25,900


4196.34478764  JPY




Common Stock


CFD


Increasing long position


142,000


4199.52323944  JPY




Common Stock


CFD


Increasing long position


110,900


4199.54165915  JPY




Common Stock


CFD


Increasing long position


36,600


4201.92622951  JPY




Common Stock


CFD


Increasing long position


1,000


4206.2  JPY




Common Stock


CFD


Increasing long position


100


4223.5  JPY




Common Stock


CFD


Increasing short position


-33,500


4197.31641791  JPY




Common Stock


CFD


Increasing short position


-32,700


4208.67980296  JPY




Common Stock


CFD


Reducing long position


-200


4181.5  JPY




Common Stock


CFD


Reducing long position


-2,500


4193  JPY




Common Stock


CFD


Reducing long position


-25,100


4195.02310757  JPY




Common Stock


CFD


Reducing long position


-800


4201.125  JPY




Common Stock


CFD


Reducing long position


-3,800


4202.28947368  JPY




Common Stock


CFD


Reducing long position


-66,000


4203.74295775  JPY




Common Stock


CFD


Reducing long position


-35,400


4203.74295775  JPY




Common Stock


CFD


Reducing long position


-27,900


4203.74295775  JPY




Common Stock


CFD


Reducing long position


-10,700


4203.74295775  JPY




Common Stock


CFD


Reducing long position


-1,200


4203.74295775  JPY




Common Stock


CFD


Reducing long position


-700


4203.74295775  JPY




Common Stock


CFD


Reducing long position


-100


4203.74295775  JPY




Common Stock


CFD


Reducing long position


-44,100


4205.27960199  JPY




Common Stock


CFD


Reducing long position


-36,600


4205.27960199  JPY




Common Stock


CFD


Reducing long position


-19,800


4205.27960199  JPY




Common Stock


CFD


Reducing long position


-300


4205.33333333  JPY




Common Stock


CFD


Reducing long position


-100


4206.5  JPY




Common Stock


CFD


Reducing long position


-16,400


4206.895753  JPY




Common Stock


CFD


Reducing long position


-15,500


4206.895753  JPY




Common Stock


CFD


Reducing long position


-9,400


4206.895753  JPY




Common Stock


CFD


Reducing long position


-5,100


4206.895753  JPY




Common Stock


CFD


Reducing long position


-4,100


4206.895753  JPY




Common Stock


CFD


Reducing long position


-900


4206.895753  JPY




Common Stock


CFD


Reducing long position


-200


4206.895753  JPY




Common Stock


CFD


Reducing long position


-100


4206.895753  JPY




Common Stock


CFD


Reducing long position


-100


4206.895753  JPY




Common Stock


CFD


Reducing long position


-35,700


4207.4789916  JPY




Common Stock


CFD


Reducing long position


-7,900


4208.67980296  JPY




Common Stock


CFD


Reducing long position


-1,000


4209.65  JPY




Common Stock


CFD


Reducing long position


-100


4218.75  JPY




Common Stock


CFD


Reducing short position


5,300


4186.62222222  JPY




Common Stock


CFD


Reducing short position


40,800


4186.62222222  JPY




Common Stock


CFD


Reducing short position


26,200


4195.88167939  JPY



















































































































(c)        Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying





































































































Class of relevant security
 


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit











































































































(ii)        Exercise





























































































Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit















































































































(d)        Other dealings (including subscribing for new securities)

























































































Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable)











































































































4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements





















































































Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




None





















































































(b)        Agreements, arrangements or understandings relating to options or derivatives





















































































Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




None

















































































(c)        Attachments

















































































Is a Supplemental Form 8 (Open Positions) attached?


NO





















































































 Date of disclosure:


05 December, 2018




 Contact name:


Jamison Van Doesburg




 Telephone number*:


020 7645 9700





















































































Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.






























































































































 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETUVVRRWOAURAA